Ondine Biomedical Inc. (AIM:OBI)
London
· Delayed Price · Currency is GBP · Price in GBX 16.25
+1.75 (12.07%)
Aug 15, 2025, 5:40 PM GMT+1
Ondine Biomedical Market Cap
Ondine Biomedical has a market cap or net worth of 72.19 million as of August 15, 2025. Its market cap has increased by 235.92% in one year.
Market Cap
72.19M
Enterprise Value
66.86M
Revenue
1.14M
Ranking
n/a
PE Ratio
n/a
Stock Price
16.25
Market Cap Chart
Since December 6, 2021, Ondine Biomedical's market cap has decreased from 112.86M to 72.19M, a decrease of -36.04%. That is a compound annual growth rate of -11.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 72.19M | 103.03% |
| Dec 31, 2024 | 35.55M | 79.20% |
| Dec 29, 2023 | 19.84M | -50.26% |
| Dec 30, 2022 | 39.89M | -63.06% |
| Dec 31, 2021 | 107.99M | -4.31% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 179.66B |
| GSK plc | 56.72B |
| Haleon | 32.11B |
| Smith & Nephew | 11.81B |
| ConvaTec Group | 4.67B |
| Hikma Pharmaceuticals | 3.96B |
| Oxford Nanopore Technologies | 2.04B |
| HUTCHMED (China) | 2.01B |